Prescription drug · BLA
Creon (Pancrelipase) NDC 0032-2636
Pancrelipase lipase 24000 [USP'U]/1 + 2 more ingredients · Capsule, Delayed release pellets · Oral · AbbVie Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0032-2636-01 | 00032263601 | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-01)Marketed from Oct 12, 2023 | |
| 0032-2636-30 | 00032263630 | 24 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-30)Marketed from Oct 12, 2023 · Sample package | |
| 0032-2636-70 | 00032263670 | 240 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-70)Marketed from Oct 12, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Creon
- Generic name (nonproprietary)
- pancrelipase
- Active ingredients
- Pancrelipase lipase — 24000 [USP'U]/1Pancrelipase protease — 76000 [USP'U]/1Pancrelipase amylase — 120000 [USP'U]/1
- Dosage form
- Capsule, Delayed release pellets
- Route
- Oral
- Labeler
- AbbVie Inc.NDC labeler code 0032
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 020725
- Marketing start
- Listing expires
- Identifiers
- Product ID 0032-2636_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87SPL ID a43ddd93-7d01-4bb9-95e3-b0629fe8ac87SPL set ID 073201aa-556d-4a70-918e-84e9616fd88dRxCUI 855495, 855499, 855503, 863829, 863836, 863841, 1113042, 1113046, 1373325, 1373327UNII 3560D81V50, YOJ58O116E, 8MYC33932OUPC 0300322637701, 0300320045706, 0300320047700, 0300320046703, 0300323016130, 0300322636704, 0300321212077, 0300321224018
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400032263601followed by a unit qualifier and the quantityPackage 00032-2636-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. CREON is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
Excerpt only. Read the full label for complete information.
About NDC 0032-2636
- What is NDC 0032-2636?
- 0032-2636 is the product NDC for Creon (pancrelipase), Pancrelipase lipase 24000 [USP'U]/1 + 2 more ingredients capsule, delayed release pellets, listed with the FDA by AbbVie Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Creon (Pancrelipase).
- What is the active ingredient?
- Pancrelipase lipase, Pancrelipase protease, Pancrelipase amylase.
- Who is the labeler?
- AbbVie Inc., NDC labeler code 0032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Creon?
- 9 other product NDCs are listed under this name. See all Creon NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Creon products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Creonpancrelipase | Pancrelipase amylase 30000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-0046 | 00032-0046-3000032-0046-70 |
| Creonpancrelipase | Pancrelipase lipase 36000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-2637 | 00032-2637-0100032-2637-3000032-2637-70 |
| Creonpancrelipase | Pancrelipase amylase 60000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-0047 | 00032-0047-3000032-0047-70 |
| Creonpancrelipase | Pancrelipase amylase 15000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed releaseOral | AbbVie Inc. | 0032-0045 | 00032-0045-3000032-0045-70 |
| Creonpancrelipase | Pancrelipase lipase 36000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-3016 | 00032-3016-1200032-3016-1300032-3016-28 |
| Creonpancrelipase | Pancrelipase amylase 15000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed releaseOral | AbbVie Inc. | 0032-1203 | 00032-1203-6400032-1203-70 |
| Creonpancrelipase | Pancrelipase lipase 24000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1224 | 00032-1224-0100032-1224-0700032-1224-46 |
| Creonpancrelipase | Pancrelipase amylase 30000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1206 | 00032-1206-0100032-1206-0700032-1206-56 |
| Creonpancrelipase | Pancrelipase amylase 60000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1212 | 00032-1212-0100032-1212-0700032-1212-13 |
Other NDCs under BLA 020725
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Creonpancrelipase | Pancrelipase amylase 60000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1212 |
| Creonpancrelipase | Pancrelipase amylase 15000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed releaseOral | AbbVie Inc. | 0032-1203 |
| Creonpancrelipase | Pancrelipase amylase 30000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-0046 |
| Creonpancrelipase | Pancrelipase lipase 36000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-2637 |
| Creonpancrelipase | Pancrelipase lipase 24000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1224 |
| Creonpancrelipase | Pancrelipase amylase 30000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-1206 |
| Creonpancrelipase | Pancrelipase amylase 60000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-0047 |
| Creonpancrelipase | Pancrelipase lipase 36000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | AbbVie Inc. | 0032-3016 |
| Creonpancrelipase | Pancrelipase amylase 15000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed releaseOral | AbbVie Inc. | 0032-0045 |